Tag: Newer

MONDAY, Oct. 19, 2020 — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated with a standard disease-modifying antirheumatic drug (DMARD),

In the United States, ovarian cancer has the highest mortality rate of all gynecologic cancers, according to the Centers for Disease Control and Prevention (CDC). In 2014, for instance, over 21,000 new cases of ovarian cancer occurred, at least 14,000 of which resulted in death. Previous research has suggested that combined oral contraceptives — that

New types of combined oral contraceptives (containing both lower doses of oestrogens and newer progestogens) are associated with a reduced risk of ovarian cancer, in young women, finds a large study published by The BMJ today. The results show that this positive effect strengthened with longer periods of use and persisted for several years after